The reporter learned from relevant persons from the Ministry of Health that the Ministry of Health has issued a task to health bureaus in various places in recent days and requested that in 2012, the scope of implementation of the basic medicine system be further expanded, and the implementation of the basic medicine system in rural health clinics should be promoted.

It is understood that the Ministry of Health requires all health bureaus to further improve the comprehensive evaluation index system for pharmaceutical companies and pharmaceuticals. For the exclusive varieties, shortage of essential medicines, and suitable dosage forms for children, trials have been made for national uniform pricing and fixed-point production. And encourage qualified areas to conduct electronic transactions.

At the same time, formulate management methods for the use of essential medicines in medical institutions, and revise the “Guidelines for the Clinical Application of National Essential Drugs” and the “National Essential Drug Formulary”.

The basic medicine system was formally introduced and implemented in August 2009, but in the practice of more than two years, due to basic medicines and local supplements, the prices are lower, and in the context of the drug eradication model, the “cheap” "Medicine" has not really played the role of reducing people's medical expenses. But the variety of "cheap drugs" is incomplete, and it is even harder to see at the primary medical institutions.

In view of the above situation, the Ministry of Health requires all health bureaus to analyze and evaluate the status of basic drug purchases in the previous phase, and to study and propose incentives for the preferential use of essential drugs. And to carry out a comprehensive evaluation of the clinical use of essential drugs, and gradually standardize the basic drug formulations, specifications and packaging. To enrich and increase monitoring points for basic drug systems, and constantly improve the monitoring and evaluation system.

It is understood that this year, while consolidating the implementation of the national essential medicine system by primary health care institutions, it will also expand the scope of implementation of the national essential medicine system, including promoting the implementation of the national essential medicine system in village clinics, encouraging local governments to adopt services, etc., and gradually Non-government-level grass-roots medical and health institutions are included in the scope of implementation.

According to relevant sources, the implementation of essential medicines is promoted from the bottom up, and other health care institutions are gradually fully equipped and given priority in the use of essential medicines, and the preparation of the National Essential Drugs Catalogue (2012 edition) applicable to medical and health institutions at all levels is formulated. Working and regulating local additions to non-catalogue drugs have a catalytic effect. (Wen Shuping)

Other Intermediates

We are a manufacturer and supplier of raw materials and intermediates for pharmaceuticals. Our focus is on providing customers with high quality, fair priced products, coupled with our broad range of technical know-hows on fundamentals, vast industrial experience on applications, professional expertise on health and safety, and efficient logistics on customer services. Our intermediates products range covers many different kinds of API, we have established good market for our intermediates in India, Korea and EU. Besides the products of Ziprasidone Intermediates, Ibrutinib Intermediates, LCZ696 Intermediates, Palbociclib Intermediates and Tazobactam intermediates, we have other strong intermediates like Tazobactam intermediate with CAS No. 288-36-8.

All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.

Pharmaceutical Intermediates

Other Intermediates,Tazobactam Intermediate,Pharmaceutical Intermediates,Dye Intermediate

Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com